Randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy and safety of the denosumab biosimilar MW031 in Chinese postmenopausal women with osteoporosis
Article in Expert Opinion on Biological Therapy (May 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Expert Opinion on Biological Therapy (May 2024)
Book chapter (January 2023)